Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial
- 1 November 2001
- journal article
- clinical trial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 44 (11), 2539-2547
- https://doi.org/10.1002/1529-0131(200111)44:11<2539::aid-art434>3.0.co;2-t
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A 5-year randomized controlled, double-blind study of glycosaminoglycan polysulphuric acid complex (Rumalon®) as a structure modifying therapy in osteoarthritis of the hip and kneeOsteoarthritis and Cartilage, 2000
- Effects of diacerhein on granuloma induced cartilage breakdown in the mouseOsteoarthritis and Cartilage, 1998
- DiacereinDrugs, 1997
- Assessing the minimal important difference in symptoms: A comparison of two techniquesJournal of Clinical Epidemiology, 1996
- Radiological progression of hip osteoarthritis: definition, risk factors and correlations with clinical status.Annals Of The Rheumatic Diseases, 1996
- Update on the epidemiology of the rheumatic diseasesCurrent Opinion in Rheumatology, 1996
- Role of interleukin‐1, tumor necrosis factor α, and interleukin‐6 in cartilage proteoglycan metabolism and destruction effect of in situ blocking in murine antigen‐ and zymosan‐induced arthritisArthritis & Rheumatism, 1995
- Radiographic progression of hospital referred osteoarthritis of the hip.Annals Of The Rheumatic Diseases, 1993
- The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hipArthritis & Rheumatism, 1991
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986